JP2018537076A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018537076A5 JP2018537076A5 JP2018520493A JP2018520493A JP2018537076A5 JP 2018537076 A5 JP2018537076 A5 JP 2018537076A5 JP 2018520493 A JP2018520493 A JP 2018520493A JP 2018520493 A JP2018520493 A JP 2018520493A JP 2018537076 A5 JP2018537076 A5 JP 2018537076A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- nucleic acid
- isolated nucleic
- catalytic
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562245978P | 2015-10-23 | 2015-10-23 | |
| US62/245,978 | 2015-10-23 | ||
| US201662382691P | 2016-09-01 | 2016-09-01 | |
| US62/382,691 | 2016-09-01 | ||
| PCT/US2016/058429 WO2017070654A1 (en) | 2015-10-23 | 2016-10-24 | Programmable universal cell receptors and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018537076A JP2018537076A (ja) | 2018-12-20 |
| JP2018537076A5 true JP2018537076A5 (enExample) | 2019-09-19 |
Family
ID=58558187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018520493A Pending JP2018537076A (ja) | 2015-10-23 | 2016-10-24 | プログラム可能な普遍的細胞受容体およびその使用法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20170112878A1 (enExample) |
| EP (1) | EP3365016A4 (enExample) |
| JP (1) | JP2018537076A (enExample) |
| KR (1) | KR20180091820A (enExample) |
| CN (1) | CN108883170A (enExample) |
| AU (1) | AU2016341321A1 (enExample) |
| CA (1) | CA3002774A1 (enExample) |
| EA (1) | EA201890941A1 (enExample) |
| TW (1) | TW201726914A (enExample) |
| UY (1) | UY36961A (enExample) |
| WO (1) | WO2017070654A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017070654A1 (en) * | 2015-10-23 | 2017-04-27 | Sorrento Therapeutics, Inc. | Programmable universal cell receptors and methods of using the same |
| EP3448987A4 (en) | 2016-04-29 | 2020-05-27 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| WO2019010201A1 (en) * | 2017-07-03 | 2019-01-10 | Yale University | REGULATED SMALL MOLECULE ADAPTER |
| KR20200076732A (ko) | 2017-11-03 | 2020-06-29 | 소렌토 쎄라퓨틱스, 인코포레이티드 | Cd38-지시된 키메라 항원 수용체 작제물 |
| SG11202008568WA (en) | 2018-03-09 | 2020-10-29 | Sorrento Therapeutics Inc | Dimeric antigen receptors (dar) |
| CN114846030A (zh) * | 2019-10-23 | 2022-08-02 | 佛罗里达大学研究基金会公司 | 催化抗体38c2的新型缀合化学 |
| EP4114415A1 (en) * | 2020-03-06 | 2023-01-11 | Sorrento Therapeutics, Inc. | Innate immunity killer cells targeting psma positive tumor cells |
| CN116601174A (zh) * | 2020-10-12 | 2023-08-15 | 索伦托药业有限公司 | Cd19定向的嵌合抗原受体构建体 |
| CN117321079A (zh) * | 2021-01-11 | 2023-12-29 | 优特力克斯有限公司 | 包含抗4-1bb抗体及pd-1蛋白或其片段的双特异性表位结合蛋白及其用途 |
| US20240197881A1 (en) * | 2021-04-23 | 2024-06-20 | Sorrento Therapeutics, Inc. | Dimeric Antigen Receptors (DARs) that Bind GD2 |
| WO2023154708A2 (en) * | 2022-02-10 | 2023-08-17 | The Scripps Research Institute | Car-t therapies targeted via covalently bonded adapters |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6268488B1 (en) * | 1999-05-25 | 2001-07-31 | Barbas, Iii Carlos F. | Prodrug activation using catalytic antibodies |
| CA2515100A1 (en) * | 2003-02-06 | 2004-08-19 | Micromet Ag | Trimeric polypeptide construct to induce an enduring t cell response |
| DK2187965T3 (da) * | 2007-08-17 | 2020-01-20 | Purdue Research Foundation | Psma-bindingsligand-linker-konjugater og fremgangsmåder til anvendelse |
| JP5934099B2 (ja) * | 2009-10-01 | 2016-06-15 | アメリカ合衆国 | 抗血管内皮増殖因子受容体−２キメラ抗原受容体及び癌の治療のためのその使用 |
| SG186451A1 (en) * | 2010-07-12 | 2013-01-30 | Covx Technologies Ireland Ltd | Multifunctional antibody conjugates |
| PH12013501201A1 (en) * | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| EP3459560B1 (en) * | 2011-04-08 | 2021-02-24 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer |
| US9708384B2 (en) * | 2011-09-22 | 2017-07-18 | The Trustees Of The University Of Pennsylvania | Universal immune receptor expressed by T cells for the targeting of diverse and multiple antigens |
| US10851178B2 (en) * | 2011-10-10 | 2020-12-01 | Xencor, Inc. | Heterodimeric human IgG1 polypeptides with isoelectric point modifications |
| WO2017070654A1 (en) * | 2015-10-23 | 2017-04-27 | Sorrento Therapeutics, Inc. | Programmable universal cell receptors and methods of using the same |
-
2016
- 2016-10-24 WO PCT/US2016/058429 patent/WO2017070654A1/en not_active Ceased
- 2016-10-24 EP EP16858424.1A patent/EP3365016A4/en not_active Withdrawn
- 2016-10-24 CA CA3002774A patent/CA3002774A1/en not_active Abandoned
- 2016-10-24 CN CN201680076271.2A patent/CN108883170A/zh active Pending
- 2016-10-24 EA EA201890941A patent/EA201890941A1/ru unknown
- 2016-10-24 US US15/333,115 patent/US20170112878A1/en not_active Abandoned
- 2016-10-24 AU AU2016341321A patent/AU2016341321A1/en not_active Abandoned
- 2016-10-24 UY UY0001036961A patent/UY36961A/es not_active Application Discontinuation
- 2016-10-24 TW TW105134363A patent/TW201726914A/zh unknown
- 2016-10-24 JP JP2018520493A patent/JP2018537076A/ja active Pending
- 2016-10-24 KR KR1020187014623A patent/KR20180091820A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7605912B2 (ja) | Ｇｐｒｃ５ｄキメラ抗原受容体及びそれを発現する細胞 | |
| JP7291196B2 (ja) | 抗ヒトパピローマウイルス１６ ｅ７ ｔ細胞受容体 | |
| JP6633081B2 (ja) | 細胞 | |
| JP7179030B2 (ja) | Ｒｏｒ１ ｃａｒ ｔ細胞 | |
| JP2022109915A (ja) | Ｃｄ８０バリアント免疫調節タンパク質およびその使用 | |
| JP7313746B2 (ja) | キメラ抗原受容体及び当該キメラ抗原受容体を発現する免疫エフェクター細胞 | |
| KR20200015713A (ko) | 항-trbc1 항원 결합 도메인 | |
| JP2015513920A5 (enExample) | ||
| EP3773630A1 (en) | Bcma-car-t cells | |
| CN114401989A (zh) | 靶向bcma的抗体及嵌合抗原受体 | |
| JP7584453B2 (ja) | Ｔａｃｉを標的とする抗体及びキメラ抗原受容体 | |
| CN110616191A (zh) | 共刺激配体联合的car t疗法 | |
| CN110461363B (zh) | 靶向cd37的嵌合抗原受体 | |
| JP2022513460A5 (enExample) | ||
| JP2020532969A5 (enExample) | ||
| CN116162168A (zh) | 分子开关调控型嵌合抗原受体细胞和抗体的组合及其应用 | |
| US20250236864A1 (en) | CAR LIBRARY AND scFv MANUFACTURING METHOD | |
| CN114685659A (zh) | Cd22特异性人源化抗体及利用其的嵌合抗原受体 | |
| US20210079111A1 (en) | Cd19-cd20 bispecific and dual passway car-t and methods for use thereof | |
| JP2026500705A (ja) | Ｒｏｒ１を標的とする抗原結合タンパク質 | |
| JP2023549441A5 (enExample) | ||
| WO2024210072A1 (ja) | キメラタンパク質、核酸、ベクター、ｔ細胞又はｎｋ細胞、医薬組成物、組み合わせ物、組み合わせ医薬、及び標的抗原結合タンパク質 | |
| CN118541394A (zh) | 分泌team的抗间皮素car t细胞及其使用方法 | |
| Angyal et al. | Possible therapeutic applications of single-chain antibodies in systemic autoimmune diseases |